SBC Medical Group (NASDAQ:SBC) Stock Rating Lowered by Wall Street Zen

Key Points

• SBC Medical Group has been downgraded by Wall Street Zen from a "buy" to a "hold" rating.
• The company's recent quarterly earnings reported an EPS of $0.02, significantly missing the consensus estimate of $0.14.
• Institutional investors hold 60.82% of SBC Medical Group's stock, indicating strong interest from hedge funds in the company.

SBC Medical Group (NASDAQ:SBC - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Friday.

SBC Medical Group Stock Up 2.0%

SBC opened at $4.15 on Friday. The company has a market cap of $431.10 million, a PE ratio of 12.97 and a beta of 1.27. SBC Medical Group has a twelve month low of $2.62 and a twelve month high of $12.50. The company has a 50-day moving average price of $4.52 and a 200 day moving average price of $4.14. The company has a quick ratio of 3.95, a current ratio of 3.98 and a debt-to-equity ratio of 0.03.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last posted its quarterly earnings data on Wednesday, August 13th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.12). The firm had revenue of $43.36 million for the quarter, compared to analysts' expectations of $44.71 million. SBC Medical Group had a return on equity of 20.76% and a net margin of 17.71%. Sell-side analysts expect that SBC Medical Group will post 5.02 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SBC Medical Group

Hedge funds and other institutional investors have recently modified their holdings of the business. XTX Topco Ltd acquired a new position in SBC Medical Group during the second quarter worth about $64,000. New York State Common Retirement Fund purchased a new position in SBC Medical Group in the 2nd quarter worth approximately $104,000. SBI Securities Co. Ltd. boosted its holdings in shares of SBC Medical Group by 227.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after purchasing an additional 37,623 shares during the last quarter. Finally, Geode Capital Management LLC purchased a new stake in shares of SBC Medical Group in the second quarter valued at approximately $455,000. 60.82% of the stock is owned by hedge funds and other institutional investors.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.